A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border

BACKGROUND: Artemisinin and artemisinin-based combination therapy (ACT) partner drug resistance in Plasmodium falciparum have spread across the Greater Mekong Subregion compromising antimalarial treatment. The current 3-day artemether-lumefantrine regimen has been associated with high treatment fail...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Med
Autori principali: Saito, Makoto, Carrara, Verena I., Gilder, Mary Ellen, Min, Aung Myat, Tun, Nay Win, Pimanpanarak, Mupawjay, Viladpai-nguen, Jacher, Paw, Moo Kho, Haohankhunnatham, Warat, Konghahong, Kamonchanok, Phyo, Aung Pyae, Chu, Cindy, Turner, Claudia, Lee, Sue J., Duanguppama, Jureeporn, Imwong, Mallika, Bancone, Germana, Proux, Stephane, Singhasivanon, Pratap, White, Nicholas J., Nosten, François, McGready, Rose
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191049/
https://ncbi.nlm.nih.gov/pubmed/34107963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-02002-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi